Effects of OspA Vaccination on Lyme Disease Serologic Testing
AUTOR(ES)
Aguero-Rosenfeld, Maria E.
FONTE
American Society for Microbiology
RESUMO
This study presents the effects of OspA vaccination on two-step testing for Borrelia burgdorferi antibodies. Although vaccinees developed enzyme-linked immunosorbent assay reactivity, immunoblots did not fulfill Centers for Disease Control and Prevention criteria for positivity. Furthermore, OspA reactivity did not interfere with interpretation of immunoblots with sera from patients who developed early Lyme disease despite vaccination.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85737Documentos Relacionados
- Recombinant Assay for Serodiagnosis of Lyme Disease Regardless of OspA Vaccination Status
- Effect of Immunization with Recombinant OspA on Serologic Tests for Lyme Borreliosis
- Long-term protection of mice from Lyme disease by vaccination with OspA.
- Early and specific antibody response to OspA in Lyme Disease.
- Evaluation of Whole-Cell and OspC Enzyme-Linked Immunosorbent Assays for Discrimination of Early Lyme Borreliosis from OspA Vaccination